Advanced drug delivery reviews最新文献

筛选
英文 中文
Optical coherence tomography for noninvasive monitoring of drug delivery 光学相干断层扫描无创监测给药
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-03-24 DOI: 10.1016/j.addr.2025.115571
Salavat R. Aglyamov, Kirill V. Larin
{"title":"Optical coherence tomography for noninvasive monitoring of drug delivery","authors":"Salavat R. Aglyamov,&nbsp;Kirill V. Larin","doi":"10.1016/j.addr.2025.115571","DOIUrl":"10.1016/j.addr.2025.115571","url":null,"abstract":"<div><div>Optical Coherence Tomography (OCT) has revolutionized various medical imaging and diagnostics fields, offering unprecedented insights into the microstructural compositions of biological tissues. In recent years, OCT applications have been extended to noninvasive drug delivery monitoring, which is a critical aspect of many therapeutic procedures and pharmacokinetic studies. Such an extension is strongly enhanced by the inherent combination with 3D anatomical images provided by OCT. This review presents an overview of the principles of OCT technology, its functional extensions for drug delivery systems, and its advancements in monitoring therapeutic interventions. We discuss its advantages over traditional imaging modalities in terms of spatial resolution, depth penetration, and real-time capabilities. The paper highlights significant studies that have utilized OCT for the visualization and quantification of drug delivery processes, including the diffusion of injectable formulations in ocular tissues and the permeation of topical drugs through the skin. In the review, we focused on the latest OCT applications, including OCT-guided drug injection, topical drug delivery monitoring, application of OCT in inhaled drug delivery systems, and the integration of OCT with other imaging modalities.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"220 ","pages":"Article 115571"},"PeriodicalIF":15.2,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143695422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders 靶向中枢生物钟的纳米颗粒:神经系统疾病的潜在应用
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-03-20 DOI: 10.1016/j.addr.2025.115561
Marion Le Meur , Jaime Pignatelli , Paolo Blasi , Valle Palomo
{"title":"Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders","authors":"Marion Le Meur ,&nbsp;Jaime Pignatelli ,&nbsp;Paolo Blasi ,&nbsp;Valle Palomo","doi":"10.1016/j.addr.2025.115561","DOIUrl":"10.1016/j.addr.2025.115561","url":null,"abstract":"<div><div>Circadian rhythms and their involvement with various human diseases, including neurological disorders, have become an intense area of research for the development of new pharmacological treatments. The location of the circadian clock machinery in the central nervous system makes it challenging to reach molecular targets at therapeutic concentrations. In addition, a timely administration of the therapeutic agents is necessary to efficiently modulate the circadian clock. Thus, the use of nanoparticles in circadian clock dysfunctions may accelerate their clinical translation by addressing these two key challenges: enhancing brain penetration and/or enabling their formulation in chronodelivery systems. This review describes the implications of the circadian clock in neurological pathologies, reviews potential molecular targets and their modulators and suggests how the use of nanoparticle-based formulations could improve their clinical success. Finally, the potential integration of nanoparticles into chronopharmaceutical drug delivery systems will be described.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"220 ","pages":"Article 115561"},"PeriodicalIF":15.2,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143666065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting tumor-associated microbiome: A new aspect of modulating tumor microenvironment for cancer therapy 靶向肿瘤相关微生物组:调节肿瘤微环境治疗癌症的新视角
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-03-04 DOI: 10.1016/j.addr.2025.115554
Wantong Song, Leaf Huang
{"title":"Targeting tumor-associated microbiome: A new aspect of modulating tumor microenvironment for cancer therapy","authors":"Wantong Song,&nbsp;Leaf Huang","doi":"10.1016/j.addr.2025.115554","DOIUrl":"10.1016/j.addr.2025.115554","url":null,"abstract":"","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"220 ","pages":"Article 115554"},"PeriodicalIF":15.2,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143538654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D printing in musculoskeletal interface engineering: Current progress and future directions 三维打印在肌肉骨骼界面工程中的应用:当前进展和未来方向
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-03-01 DOI: 10.1016/j.addr.2025.115552
Tianpeng Xu , Jingdong Rao , Yongyi Mo , Avery Chik-Him Lam , Yuhe Yang , Sidney Wing-Fai Wong , Ka-Hing Wong , Xin Zhao
{"title":"3D printing in musculoskeletal interface engineering: Current progress and future directions","authors":"Tianpeng Xu ,&nbsp;Jingdong Rao ,&nbsp;Yongyi Mo ,&nbsp;Avery Chik-Him Lam ,&nbsp;Yuhe Yang ,&nbsp;Sidney Wing-Fai Wong ,&nbsp;Ka-Hing Wong ,&nbsp;Xin Zhao","doi":"10.1016/j.addr.2025.115552","DOIUrl":"10.1016/j.addr.2025.115552","url":null,"abstract":"<div><div>The musculoskeletal system relies on critical tissue interfaces for its function; however, these interfaces are often compromised by injuries and diseases. Restoration of these interfaces is complex by nature which renders traditional treatments inadequate. An emerging solution is three-dimensional printing, which allows for precise fabrication of biomimetic scaffolds to enhance tissue regeneration. This review summarizes the use of 3D printing in creating scaffolds for musculoskeletal interfaces, mainly focusing on advanced techniques such as multi-material printing, bioprinting, and 4D printing. We emphasize the significance of mimicking natural tissue gradients and the selection of appropriate biomaterials to ensure scaffold success. The review outlines state-of-the-art 3D printing technologies, varying from extrusion, inkjet and laser-assisted bioprinting, which are crucial for producing scaffolds with tailored mechanical and biological properties. Applications in cartilage-bone, intervertebral disc, tendon/ligament-bone, and muscle–tendon junction engineering are discussed, highlighting the potential for improved integration and functionality. Furthermore, we address challenges in material development, printing resolution, and the <em>in vivo</em> performance of scaffolds, as well as the prospects for clinical translation. The review concludes by underscoring the transformative potential of 3D printing to advance orthopedic medicine, offering a roadmap for future research at the intersection of biomaterials, drug delivery, and tissue engineering.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"219 ","pages":"Article 115552"},"PeriodicalIF":15.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143526224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MIDD in Japan– Implementations, challenges and opportunities MIDD在日本的实施、挑战和机遇
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-02-28 DOI: 10.1016/j.addr.2025.115553
Mayumi Hasegawa , Shinichi Kijima
{"title":"MIDD in Japan– Implementations, challenges and opportunities","authors":"Mayumi Hasegawa ,&nbsp;Shinichi Kijima","doi":"10.1016/j.addr.2025.115553","DOIUrl":"10.1016/j.addr.2025.115553","url":null,"abstract":"<div><div>In Japan, there has been a growing adoption of Model Informed Drug Development (MIDD) approaches as the rationale for optimal dose decision and modeling outputs have supported better characterizing the risk–benefit profile of a drug by accelerating development period and regulatory-approval pathways. Three primary guidelines on pharmacometric analysis tools issued in Japan between 2019 and 2020 function as a shared communication medium between pharmaceutical companies and the regulatory agency in Japan and have contributed to increasing number of MIDD applications embedded into new drug application documents. This review article describes how the Pharmaceuticals and Medical Devices Agency have been promoting the adoption of modeling and simulation and how MIDD applications have been implemented in Japan by introducing multiple case studies. The intent is to share the knowledge and to promote the harmonization of regulations globally for accelerating the appropriate utilization of MIDD tools and implementation of various new technologies. (149 words)</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"220 ","pages":"Article 115553"},"PeriodicalIF":15.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143526123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors 超越EPR效应:纳米颗粒药物输送到肿瘤的活体显微镜分析
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-02-26 DOI: 10.1016/j.addr.2025.115550
Iaroslav B. Belyaev , Olga Yu. Griaznova , Alexey V. Yaremenko , Sergey M. Deyev , Ivan V. Zelepukin
{"title":"Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors","authors":"Iaroslav B. Belyaev ,&nbsp;Olga Yu. Griaznova ,&nbsp;Alexey V. Yaremenko ,&nbsp;Sergey M. Deyev ,&nbsp;Ivan V. Zelepukin","doi":"10.1016/j.addr.2025.115550","DOIUrl":"10.1016/j.addr.2025.115550","url":null,"abstract":"<div><div>Delivery of nanoparticles (NPs) to solid tumors has long relied on enhanced permeability and retention (EPR) effect, involving permeation of NPs through a leaky vasculature with prolonged retention by reduced lymphatic drainage in tumor. Recent research studies and clinical data challenge EPR concept, revealing alternative pathways and approaches of NP delivery. The area was significantly impacted by the implementation of intravital optical microscopy, unraveling delivery mechanisms at cellular level <em>in vivo</em>. This review presents analysis of the reasons for EPR heterogeneity in tumors and describes non-EPR based concepts for drug delivery, which can supplement the current paradigm. One of the approaches is targeting tumor endothelium by NPs with subsequent intravascular drug release and gradient-driven drug transport to tumor interstitium. Others exploit various immune cells for tumor infiltration and breaking endothelial barriers. Finally, we discuss the involvement of active transcytosis through endothelial cells in NP delivery. This review aims to inspire further understanding of the process of NP extravasation in tumors and provide insights for developing next-generation nanomedicines with improved delivery.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"219 ","pages":"Article 115550"},"PeriodicalIF":15.2,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143495754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acoustic tweezers for targeted drug delivery 用于靶向药物输送的声学镊子
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-02-21 DOI: 10.1016/j.addr.2025.115551
Léa Guerassimoff , Stefaan C. De Smedt , Félix Sauvage , Michael Baudoin
{"title":"Acoustic tweezers for targeted drug delivery","authors":"Léa Guerassimoff ,&nbsp;Stefaan C. De Smedt ,&nbsp;Félix Sauvage ,&nbsp;Michael Baudoin","doi":"10.1016/j.addr.2025.115551","DOIUrl":"10.1016/j.addr.2025.115551","url":null,"abstract":"<div><div>Acoustic tweezers are a highly promising technology for targeted drug delivery thanks to their unique capabilities: (i) they can effectively operate in both <em>in vitro</em> and <em>in vivo</em> environments, (ii) they can manipulate a wide range of particle sizes and materials, and (iii) they can exert forces several orders of magnitude larger than competing techniques while remaining safe for biological tissues. In particular, tweezers capable of selectively capturing and manipulating objects in 3D with a single beam, known as ‘single beam tweezers’, open new perspectives for delivering drug carriers to precise locations. In this review, we first introduce the fundamental physical principles underlying the manipulation of particles using acoustic tweezers and highlight the latest advancements in the field. We then discuss essential considerations for the design of drug delivery carriers suitable for use with acoustic tweezers. Finally, we summarise recent promising studies that explore the use of acoustic tweezers for <em>in vitro</em>, <em>ex vivo</em>, and <em>in vivo</em> drug delivery.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"220 ","pages":"Article 115551"},"PeriodicalIF":15.2,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143470991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PhotoChem Interplays: Lighting the Way for Drug Delivery and Diagnosis 光化学相互作用:照亮药物传递和诊断的道路
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-02-20 DOI: 10.1016/j.addr.2025.115549
Asmita Banstola, Zuan-Tao Lin, Yongli Li, Mei X. Wu
{"title":"PhotoChem Interplays: Lighting the Way for Drug Delivery and Diagnosis","authors":"Asmita Banstola,&nbsp;Zuan-Tao Lin,&nbsp;Yongli Li,&nbsp;Mei X. Wu","doi":"10.1016/j.addr.2025.115549","DOIUrl":"10.1016/j.addr.2025.115549","url":null,"abstract":"<div><div>Light, a non-invasive tool integrated with cutting-edge nanotechnologies, has driven transformative advancements in imaging-based diagnosis and drug delivery for cancer and bacterial treatments. This review discusses recent progress in these areas, beginning with emerging imaging technologies. Unlike traditional photosensors activated by visible light, alternative energy sources such as near-infrared (NIR) light, X-rays, and ultrasound have been extensively investigated to activate various photosensors, achieving high sensitivity, wavelength versatility, and spatial resolution for deep-tissue imaging. Moreover, to address challenges like tissue autofluorescence in real-time fluorescence imaging, afterglow luminescent nanoparticles are being developed by integrating these alternative energy sources for real-time imaging and sensing in deep tissue for precise cancer diagnosis and treatment beyond superficial tissues. In addition to deep tissue imaging, light-responsive nanomedicines are revolutionizing anticancer and antimicrobial phototherapy by enabling spatially and temporally controlled drug release. These smart nanoparticles are engineered to release therapeutic cargo at target sites in response to microenvironmental cues specific to tumors or infections. In anticancer phototherapy, these nanoparticles facilitate controlled drug release via photoisomerization, photothermal, and photodynamic processes. To enhance circulation time and specific targeting, biomimetic nanoparticles, which mimic natural anti-tumor responses by our body, have attracted increasing attention. In antimicrobial phototherapy, research has been focused on the chemical modification of the photosensitizer to enable targeted drug delivery. An intriguing strategy has recently emerged involving the development of “pro-photosensitizers” that are specifically activated within bacterial cells upon light irradiation, offering a high margin of safety. These advancements leverage photochemical reactions and nanotechnology to enhance precision therapy and diagnosis in addressing critical health challenges.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"219 ","pages":"Article 115549"},"PeriodicalIF":15.2,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143452232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of photosensitive microalgae in targeted tumor therapy 光敏微藻在肿瘤靶向治疗中的应用
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-02-13 DOI: 10.1016/j.addr.2025.115519
Ruoxi Wang , Zhouyue Wang , Min Zhang , Danni Zhong , Min Zhou
{"title":"Application of photosensitive microalgae in targeted tumor therapy","authors":"Ruoxi Wang ,&nbsp;Zhouyue Wang ,&nbsp;Min Zhang ,&nbsp;Danni Zhong ,&nbsp;Min Zhou","doi":"10.1016/j.addr.2025.115519","DOIUrl":"10.1016/j.addr.2025.115519","url":null,"abstract":"<div><div>Microalgae present a novel and multifaceted approach to cancer therapy by modulating the tumor-associated microbiome (TAM) and the tumor microenvironment (TME). Through their ability to restore gut microbiota balance, reduce inflammation, and enhance immune responses, microalgae contribute to improved cancer treatment outcomes. As photosynthetic microorganisms, microalgae exhibit inherent anti-tumor, antioxidant, and immune-regulating properties, making them valuable in photodynamic therapy and tumor imaging due to their capacity to generate reactive oxygen species. Additionally, microalgae serve as effective drug delivery vehicles, leveraging their biocompatibility and unique structural properties to target the TME more precisely. Microalgae-based microrobots further expand their therapeutic potential by autonomously navigating complex biological environments, offering a promising future for precision-targeted cancer treatments. We position microalgae as a multifunctional agent capable of modulating TAM, offering novel strategies to enhance TME and improve the efficacy of cancer therapies.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"219 ","pages":"Article 115519"},"PeriodicalIF":15.2,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143418423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D printing of pharmaceutical dosage forms: Recent advances and applications 药物剂型的3D打印:最新进展和应用
IF 15.2 1区 医学
Advanced drug delivery reviews Pub Date : 2025-02-01 DOI: 10.1016/j.addr.2024.115504
Tobias Auel , Aaron Felix Christofer Mentrup , Lee Roy Oldfield , Anne Seidlitz
{"title":"3D printing of pharmaceutical dosage forms: Recent advances and applications","authors":"Tobias Auel ,&nbsp;Aaron Felix Christofer Mentrup ,&nbsp;Lee Roy Oldfield ,&nbsp;Anne Seidlitz","doi":"10.1016/j.addr.2024.115504","DOIUrl":"10.1016/j.addr.2024.115504","url":null,"abstract":"<div><div>Three-dimensional (3D) printing, also referred to as additive manufacturing, is considered to be a game-changing technology in many industries and is also considered to have potential use cases in pharmaceutical manufacturing, especially if individualization is desired. In this review article the authors systematically researched literature published during the last 5 years (2019 – spring 2024) on the topic of 3D printed dosage forms. Besides all kinds of oral dosage forms ranging from tablets and capsules to films, pellets, etc., numerous reports were also identified on parenteral and cutaneous dosage forms and also rectal, vaginal, dental, intravesical, and ophthalmic preparations. In total, more than 500 publications were identified and grouped according to the site of administration, and an overview of the manuscripts is presented here. Furthermore, selected publications are described and discussed in more detail. The review highlights the very different approaches that are currently used in order to develop 3D printed dosage forms but also addresses remaining challenges.</div></div>","PeriodicalId":7254,"journal":{"name":"Advanced drug delivery reviews","volume":"217 ","pages":"Article 115504"},"PeriodicalIF":15.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142849155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信